Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide Absorption with Milk/Formula in Healthy Adults
NCT03093090Phase 1Withdrawn
- Sponsor
- Yale University
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of furosemide in edema and hypertension (HTN) (4 arms), sponsored by Yale University. Primary endpoint: area under the plasma concentration curve at 4 weeks. Planned start Dec 2018; status: withdrawn.
02
Drugs
furosemide
03
Conditions
edemahypertension (HTN)
Beyond the preview
Go deeper on NCT03093090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03093090.